Company Close Updates

Moderna Inc. stock outperforms competitors on strong trading day

Company Logo

Terrence Horan

Referenced Symbols

Shares of Moderna Inc. MRNA, -3.84% advanced 3.23% to $331.88 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, -0.82% rising 1.73% to 14,823.43 and the Dow Jones Industrial Average DJIA, +0.21% rising 1.56% to 34,912.56. This was the stock's fourth consecutive day of gains. Moderna Inc. closed $165.61 below its 52-week high ($497.49), which the company reached on August 10th.

The stock outperformed some of its competitors Thursday, as AbbVie Inc. ABBV, +0.35% rose 1.57% to $108.91, Amgen Inc. AMGN, +0.12% rose 1.56% to $206.78, and AstraZeneca PLC ADR AZN, +0.93% fell 1.29% to $59.67. Trading volume (12.5 M) remained 4.4 million below its 50-day average volume of 16.9 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.